My recent biopsy shows no evidence of a new BRAC1/2 mutation so the PARB inhibitors are not an option for me as a new castration resistant metastatic prostate cancer patient.
Made the decision to remain in Phoenix to enter a clinical trial with the Mayo Clinic this month. They were kind enough to hold off closing phase 1 for one more patient. Myself. So 2 days of infusions every 2 weeks until it does not work anymore or I can’t tolerate the side effects. A new drug called PT-112 paired with immunotherapy agent avelumab. Hopefully this study will broaden our armory in the future.